| Management of Helicobacter pylori infection—the Maastricht IV/Florence consensus report P Malfertheiner, F Megraud, CA O'Morain, J Atherton, ATR Axon, ... Gut 61 (5), 646-664, 2012 | 6227* | 2012 |
| Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report P Malfertheiner, F Megraud, C O'morain, APS Hungin, R Jones, A Axon, ... Alimentary pharmacology & therapeutics 16 (2), 167-180, 2002 | 1944 | 2002 |
| Management of Helicobacter pylori infection—the Maastricht V/Florence consensus report P Malfertheiner, F Megraud, CA O'morain, JP Gisbert, EJ Kuipers, ... Gut 66 (1), 6-30, 2017 | 1626* | 2017 |
| Peptic ulcer disease P Malfertheiner, FKL Chan, KEL McColl The lancet 374 (9699), 1449-1461, 2009 | 841 | 2009 |
| Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple … P Malfertheiner, F Bazzoli, JC Delchier, K Celiński, M Gigučre, M Rivičre, ... The Lancet 377 (9769), 905-913, 2011 | 581 | 2011 |
| Meta-analysis: Can Helicobacter pylori Eradication Treatment Reduce the Risk for Gastric Cancer? L Fuccio, RM Zagari, LH Eusebi, L Laterza, V Cennamo, L Ceroni, D Grilli, ... Annals of internal medicine 151 (2), 121-128, 2009 | 502 | 2009 |
| Epidemiology of Helicobacter pylori Infection LH Eusebi, RM Zagari, F Bazzoli Helicobacter 19, 1-5, 2014 | 460 | 2014 |
| Helicobacter pylori in developing countries. World gastroenterology organisation global guideline RH Hunt, SD Xiao, F Megraud, R Leon-Barua, F Bazzoli, ... J Gastrointestin Liver Dis 20 (3), 299-304, 2011 | 430* | 2011 |
| Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano–Monghidoro study RM Zagari, L Fuccio, MA Wallander, S Johansson, R Fiocca, S Casanova, ... Gut 57 (10), 1354-1359, 2008 | 404 | 2008 |
| Short-term low-dose triple therapy for the eradication of Helicobacter pylori F Bazzoli, RM Zagari, S Fossi, P Pozzato, G Alampi, P Simoni, S Sottiliv, ... European journal of gastroenterology & hepatology 6 (9), 773-778, 1994 | 388 | 1994 |
| Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention D Colussi, G Brandi, F Bazzoli, L Ricciardiello International journal of molecular sciences 14 (8), 16365-16385, 2013 | 368 | 2013 |
| Meta-analysis: Duration of First-Line Proton-Pump Inhibitor–Based Triple Therapy for Helicobacter pylori Eradication L Fuccio, ME Minardi, RM Zagari, D Grilli, N Magrini, F Bazzoli Annals of internal medicine 147 (8), 553-562, 2007 | 336 | 2007 |
| Gallstone recurrence after successful oral bile acid treatment: a 12-year follow-up study and evaluation of long-term postdissolution treatment N Villanova, F Bazzoli, F Taroni, R Frabboni, G Mazzella, D Festi, ... Gastroenterology 97 (3), 726-731, 1989 | 228 | 1989 |
| Optimum duration of regimens for Helicobacter pylori eradication Y Yuan, AC Ford, KJ Khan, JP Gisbert, D Forman, GI Leontiadis, F Tse, ... Cochrane Database of Systematic Reviews, 2013 | 221 | 2013 |
| Guidelines in the management of obstructing cancer of the left colon: consensus conference of the world society of emergency surgery (WSES) and peritoneum and surgery (PnS) society L Ansaloni, RE Andersson, F Bazzoli, F Catena, V Cennamo, S Di Saverio, ... World Journal of Emergency Surgery 5 (1), 29, 2010 | 211 | 2010 |
| Can early precut implementation reduce endoscopic retrograde cholangiopancreatography-related complication risk? Meta-analysis of randomized controlled trials V Cennamo, L Fuccio, RM Zagari, LH Eusebi, L Ceroni, L Laterza, ... Endoscopy 42 (5), 381-388, 2010 | 201 | 2010 |
| Can a wire-guided cannulation technique increase bile duct cannulation rate and prevent post-ERCP pancreatitis?: A meta-analysis of randomized controlled trials V Cennamo, L Fuccio, RM Zagari, LH Eusebi, L Ceroni, L Laterza, ... American Journal of Gastroenterology 104 (9), 2343-2350, 2009 | 163 | 2009 |
| Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer L Fuccio, RM Zagari, ME Minardi, F Bazzoli Alimentary pharmacology & therapeutics 25 (2), 133-141, 2007 | 150 | 2007 |
| Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone‐dissolving agents: A comparative randomized study E Roda, F Bazzoli, AMM Labate, G Mazzella, A Roda, C Sama, D Festi, ... Hepatology 2 (6), 804-810, 1982 | 149 | 1982 |
| Gallbladder motility in cholesterol gallstone disease: effect of ursodeoxycholic acid administration and gallstone dissolution D Festi, R Frabboni, F Bazzoli, A Sangermano, M Ronchi, L Rossi, ... Gastroenterology 99 (6), 1779-1785, 1990 | 144 | 1990 |
